Israeli diagnostics device manufacturer Itamar Medical has secured US Food and Drug Administration (FDA) 510(k) clearance for the disposable home sleep apnoea test (HSAT), WatchPAT One.

Based on the company’s WatchPAT technology, the test is designed for use in clinics and practices with limited resources, infrastructure or capital.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

WatchPAT One can be linked to the WatchPAT device via the company’s smartphone app. The test collects sleep study data, which is automatically transmitted to Itamar Medical’s CloudPAT server.

After the completion of the test, WatchPAT’s True Sleep Time, Sleep Architecture and Central Plus algorithms are used to automatically generate a comprehensive report and send to the prescribing physician.

Itamar Medical president and CEO Gilad Glick said: “We expect the availability of a disposable WatchPAT system will improve patient access by increasing the number of physicians able to offer our cutting-edge technology to their patients.

“Additionally, as a disposable HSAT, WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company focuses on research, development, sales and marketing of non-invasive medical devices to diagnose respiratory sleep disorders.

Its portfolio includes Total Sleep Solution, designed to enable comprehensive sleep apnoea management in different clinical settings to optimise patient care and minimise healthcare costs.

In addition, Itamar Medical offers a WatchPAT home-use diagnostic device for sleep breathing disorders.

“WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

This device, which can be worn like a wrist-watch, uses finger based physiology and technology to facilitate testing for obstructive sleep apnoea.

It operates on Peripheral Arterial Tone (PAT) signal, which measures the arterial volume changes at the fingertip. These changes indicate the sympathetic nervous system activation.

The company additionally provides the EndoPAT system for testing endothelial dysfunction and to assess cardiovascular diseases risk.